Capital 10X sits down with Cresco Labs
Caltabiano talks about the recent Sunnyside* retail rollout, current and future acquisitions, and Cresco Labs’ strategy as they continue to grow into one of top U.S. cannabis companies.
The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.